Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
•
IPF
How do you counsel patients regarding prognosis following a diagnosis of IPF?
Related Questions
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
What is your approach to managing ILD associated with inflammatory bowel disease?
How long after initiating mycophenolate do you wait before tapering prednisone off in patients with myositis-associated ILD?
Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
What is your approach to evaluating amiodarone induced interstitial pneumonitis?
Do you seek pathologic confirmation before proceeding with empiric immunosuppressive therapy in symptomatic patients with radiographic NSIP?
How do you manage pleuroparenchymal fibroelastosis in a patient with seronegative RA that is progressing on Rituxan and DMARD therapy?
Would you continue or stop anticoagulation for a DVT/PE in a patient with active cancer who has completed 6 months of therapy?
What are some immunosuppression regimens to consider in a patient with refractory cardiac sarcoidosis?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
